SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing significant after-hours volatility as investors react to the CMS finalizing a Medicare Advantage payment rate increase of 2.48% for 2027, a figure that significantly outperformed initial market expectations. The community is actively debating whether this news acts as a definitive bullish catalyst to spark a short squeeze and long-term recovery or if persistent regulatory headwinds and broader sector uncertainty will continue to pressure the stock.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group is experiencing intense market volatility as investors weigh significant concerns over the company's massive debt burden and share dilution against its potential as a high-conviction short squeeze candidate. The community remains deeply divided, with bears pointing to poor fundamentals and weak analyst sentiment, while aggressive traders continue to monitor heavy short interest and institutional accumulation for signs of another rapid vertical move.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing intense downward pressure following a bearish downgrade from JPMorgan that warns of significant downside potential based on concerns over declining vehicle deliveries and market share. The community is sharply divided, with frustrated bears highlighting the stock's high valuation and missing growth metrics, while vocal bulls are dismissing the analyst note as market manipulation and continuing to buy what they perceive as a discount ahead of future AI and robotics initiatives.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana and other major health insurers are rallying following a better-than-expected Medicare Advantage payment rate announcement for 2027 that significantly eased investor concerns over margin pressure. While analysts highlight the relief provided by this regulatory outcome, the community remains actively divided between those viewing the move as a long-term recovery catalyst and others cautioning that structural utilization and margin headwinds persist.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is seeing heightened market interest and volatility as investors speculate on a potential major production order following the company's strategic pivot toward AI infrastructure and silicon photonics. The community remains deeply divided, with bulls pointing to the company's critical role in high-power reliability testing for hyperscalers, while bears remain skeptical of the timeline for these contract conversions and the impact of the company's previous reliance on the EV sector.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is gaining attention as a long-standing cultural meme, with the community actively debating whether its 15-year history and satirical roots position it as a legitimate contender to flip established assets. Discussions are centered on its transition to the blockchain and the narrative that its irreverent, "anti-establishment" nature provides a unique form of lasting value in a volatile meme coin market.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS Health is trending as market sentiment turns positive following a relief rally in the managed care sector, driven by CMS finalizing 2027 Medicare Advantage payment rates that were significantly better than previously feared. The community is actively discussing the stock's stability and technical recovery, with many traders focused on institutional accumulation patterns and the impact of the finalized payment policies on near-term earnings risk.

Owlet, Inc. is a digital parenting platform, which engages in the provision of real-time data and insights, and parenting solutions. It focuses on developing and marketing its products and content for children. It offers the Owlet BabySat, Owlet OTC Smart Sock, and Owlet Band products that allow the sharing of infant sleep and health data and also provides an end-to-end digital healthcare solution for its customers. It operates through the following geographical segments: Unites States, United Kingdom, and Other. The company was founded by Kurt Workman, Zack Bomsta, Jordan Monroe, and Jacob Colvin in 2012 and is headquartered in Lehi, UT.

Owlet Inc - Ordinary Shares - Class A

Owlet Inc. is seeing intense investor activity following a CEO transition and positive Q4 earnings that highlighted record revenue growth and a shift toward profitability. The community is buzzing over the stock's potential as a long-term value play, with active discussions focused on the company's expanding subscription model, the potential for strategic M&A, and bullish sentiment surrounding its unique position as an FDA-cleared pediatric health platform.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is currently trending following a major long-term agreement to develop and supply custom Tensor Processing Units for Google, alongside an expanded strategic collaboration that grants Anthropic access to significant AI compute capacity through 2031. While the community is actively debating whether this news justifies a fundamental rerating or if current price action reflects broader semiconductor sector caution, many investors remain bullish on Broadcom's central role in the AI infrastructure stack.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG is capturing significant market attention as supporters leverage its position as a Bitcoin-native asset to rally against traditional crypto listing practices and centralized market-making. Community discussions are heavily focused on the coin's structural advantagessuch as its fixed supply and fair launchwhile members actively coordinate social campaigns and exchange listing requests to drive momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Given Consensus Rating of "Moderate Buy" by Analysts

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the six research firms that are presently covering the company, Marketbeat.com...

X4 Pharmaceuticals (NASDAQ:XFOR) Raised to Hold at Wall Street Zen

Wall Street Zen raised shares of X4 Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Saturday...

Q3 Earnings Forecast for XFOR Issued By Brookline Cap M

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR - Free Report) - Equities research analysts at Brookline Cap M issued their Q3 2026 earnings per share estimates for shares of X4 Pharmaceuticals in a research note issued on Tuesday, March 17th. Brookline Cap M analyst L. Cann anticipates that the company will...

Research Analysts Set Expectations for XFOR Q1 Earnings

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR - Free Report) - Stock analysts at Brookline Cap M issued their Q1 2026 earnings per share estimates for shares of X4 Pharmaceuticals in a research report issued on Tuesday, March 17th. Brookline Cap M analyst L. Cann forecasts that the company will post earning...

X4 Pharmaceuticals (NASDAQ:XFOR) Issues Quarterly Earnings Results

X4 Pharmaceuticals (NASDAQ:XFOR - Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.36) by...

X4 Pharmaceuticals (XFOR) Reports Q4 Loss, Tops Revenue Estimates

X4 Pharmaceuticals (XFOR) delivered earnings and revenue surprises of +38.89% and +53.22%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

X4 Pharmaceuticals (XFOR) Projected to Post Quarterly Earnings on Tuesday

X4 Pharmaceuticals (NASDAQ:XFOR) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 24. (View Earnings Report at...

X4 Pharmaceuticals, Inc. $XFOR Shares Acquired by Kingdon Capital Management L.L.C.

Kingdon Capital Management L.L.C. increased its holdings in X4 Pharmaceuticals, Inc. (NASDAQ:XFOR - Free Report) by 300.0% in the third quarter, according to the company in its most recent Form 13F...

Rosalind Advisors Inc. Makes New Investment in X4 Pharmaceuticals, Inc. $XFOR

Rosalind Advisors Inc. acquired a new stake in shares of X4 Pharmaceuticals, Inc. (NASDAQ:XFOR - Free Report) in the third quarter, according to its most recent filing with the Securities and...

ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates

ProQR (PRQR) delivered earnings and revenue surprises of -12.50% and -36.14%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

X4 Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. It is focused on mavorixafor which is being marketed in the U.S. under the trade name xolremdi. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.

Current Price	$4.07
Prev Close	$4.24
Open	$4.24
Dividend Yield	0.00%
50-Day Moving Average	$3.75
Beta	1.51
Avg. Volume	529,721.26
PE Ratio	-0.94

52-Week High	$6.96
52-Week Low	$1.35
Market Capitalization	$385.5M
EPS (Annual)	-$1.87
Price to Book	1.99
Revenue Per Employee	$780,288.89

XFOR
X4 Pharmaceuticals Inc

Feed

News

Sentiment

Fundamentals

Info

Latest XFOR News

XFORX4 Pharmaceuticals Inc